Awareness of patients with multiple sclerosis in Saudi Arabia regarding the relationship between smoking and multiple sclerosis

References

1. ↵
   1. Moss BP,
   2. Rensel MR,
   3. Hersh CM

   (2017) Wellness and the Role of Comorbidities in Multiple Sclerosis. Neurotherapeutics 14, 999–1017.
2. ↵
   1. Mohammed E

   (2016) Multiple sclerosis is prominent in the Gulf states [Review]. Pathogenesis 3, 19–38.
3. ↵
   1. Wallin MT,
   2. Culpepper WJ,
   3. Nichols E,
   4. Bhutta ZA,
   5. Gebrehiwot TT,
   6. Hay SI,
   7. Khalil IA,
   8. Krohn KJ,
   9. Liang X,
   10. Naghavi M,
   11. Mokdad AH

   (2019) Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18, 269–285.
4. ↵
   1. Howard J,
   2. Trevick S,
   3. Younger DS

   (2016) Epidemiology of multiple sclerosis. Neurol Clin 34, 919–939.
5. ↵
   1. Tejera-Alhambra M,
   2. Casrouge A,
   3. de Andrés C,
   4. Seyfferth A,
   5. Ramos-Medina R,
   6. Alonso B,
   7. et al.

   (2015) Plasma biomarkers discriminate clinical forms of multiple sclerosis. PLoS One 10, e0128952.
6. ↵
   1. Dendrou CA,
   2. Fugger L,
   3. Friese MA

   (2015) Immunopathology of multiple sclerosis. Nat Rev Immunol 15, 545–558.
7. ↵
   1. Ramagopalan SV,
   2. Dobson R,
   3. Meier UC,
   4. Giovannoni G

   (2010) Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 9, 727–739.
8. ↵
   1. Belbasis L,
   2. Bellou V,
   3. Evangelou E,
   4. Ioannidis JP,
   5. Tzoulaki I

   (2015) Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol 14, 263–273.
9. ↵
   1. Newland P,
   2. Flick L,
   3. Salter A,
   4. Dixon D,
   5. Jensen MP

   (2017) The link between smoking status and co-morbid conditions in individuals with multiple sclerosis (MS). Disabil Health J 10, 587–591.
10. ↵
    1. GBD 2015 Tobacco Collaborators

    (2017) Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet 389, 1885–1906.
11. ↵
    1. Tanasescu R,
    2. Constantinescu C,
    3. Tench C,
    4. Manouchehrinia A

    (2018) Smoking Cessation and the Reduction of Disability Progression in Multiple Sclerosis: A Cohort Study. Nicotine Tob Res 20, 589–595.
12. ↵
    1. Abdollahpour I,
    2. Nedjat S,
    3. Sahraian MA,
    4. Mansournia MA,
    5. Otahal P,
    6. van der Mei I

    (2017) Waterpipe smoking associated with multiple sclerosis: A population-based incident case-control study. Mult Scler 23, 1328–1335.
13. ↵
    1. Ramanujam R,
    2. Hedström AK,
    3. Manouchehrinia A,
    4. Alfredsson L,
    5. Olsson T,
    6. Bottai M,
    7. et al.

    (2015) Effect of smoking cessation on multiple sclerosis prognosis. JAMA Neurol 72, 1117–1123.
14. ↵
    1. Turner AP,
    2. Hartoonian N,
    3. Maynard C,
    4. Leipertz SL,
    5. Haselkorn JK

    (2015) Smoking and physical activity: examining health behaviors and 15-year mortality among individuals with multiple sclerosis. Arch Phys Med Rehabil 96, 402–409.
15. ↵
    1. NHIS - Adult Tobacco Use - Glossary [Internet]. Cdc.gov

    (2019) Available from: https://www.cdc.gov/nchs/nhis/tobacco/tobacco_glossary.htm. [cited 14 July 2019].
16. ↵
    1. Algabbani A,
    2. Almubark R,
    3. Althumiri N,
    4. Alqahtani A,
    5. BinDhim N

    (2018) The Prevalence of Cigarette Smoking in Saudi Arabia in. Food and Drug Regulatory Science Journal 1, 1–1.
17. ↵
    1. Cosgrove KP,
    2. Wang S,
    3. Kim SJ,
    4. McGovern E,
    5. Nabulsi N,
    6. Gao H,
    7. et al.

    (2014) Sex differences in the brain’s dopamine signature of cigarette smoking. J Neurosci 34, 16851–16855.
18. ↵
    1. Hagen EH,
    2. Garfield MJ,
    3. Sullivan RJ

    (2016) The low prevalence of female smoking in the developing world: gender inequality or maternal adaptations for fetal protection? Evol Med Public Health 2016, 195–211.
19. ↵
    1. Hudaif H,
    2. Bwardi N,
    3. Kojan S

    (2014) Assessment of multiple sclerosis awareness and knowledge among the Saudi population in Riyadh City. Mult Scler Relat Disord 3, 758.
20. ↵
    1. Amer M,
    2. AlZahrani W,
    3. AlZahrani A,
    4. Altalhi F,
    5. Alrubaie S,
    6. Alsini R,
    7. et al.

    (2016) Assessment of multiple sclerosis awareness: knowledge and attitude among Saudi population in Taif city, KSA. International Journal of Advanced Research 4, 1758–1766.
21. ↵
    1. McKay KA,
    2. Tremlett H,
    3. Fisk JD,
    4. Patten SB,
    5. Fiest K,
    6. Berrigan L,
    7. et al.

    (2016) Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: A prospective multisite study. Mult Scler 22, 685–693.
22. ↵
    1. Pippo A,
    2. Llambi L,
    3. Parodi C,
    4. Barros M,
    5. Nuñez V,
    6. Silveira A

    (2016) Missed opportunities of tobacco cessation interventions in hospitalized patients. J Fam Med 3, 1089.
23. ↵
    1. Ng L,
    2. Young J,
    3. Hii S,
    4. Amatya B

    (2018) Effectiveness of a smoking cessation programme in an Australian inpatient rehabilitation setting. Int J Ther Rehabil 25, 199–206.
24. ↵
    1. Champassak SL,
    2. Catley D,
    3. Finocchario-Kessler S,
    4. Farris M,
    5. Ehtesham M,
    6. Schoor R,
    7. et al.

    (2014) Physician smoking cessation counseling and adherence to a clinical practice guideline. Eur J Pers Cent Healthc 2, 477–484.
25. ↵
    (2008) Treating tobacco use and dependence. [Rockville, Md.] U.S. Dept. of Health and Human Services, Public Health Service.
26. ↵
    1. Mannino DM

    (2009) Why won’t our patients stop smoking? The power of nicotine addiction. Diabetes Care 32, S426–S428.
27. ↵
    1. Baumeister RF

    (2017) Addiction, cigarette smoking, and voluntary control of action: Do cigarette smokers lose their free will? Addict Behav Rep 5, 67–84.